ArticleESMO real world data and digital oncology2026

Multi-site validation of an AI-based biomarker test for determining ER, PR, and HER2 status from H&E-stained breast cancer slides.

F Ntelemis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.